Redefining Precision Therapeutics in Hematologic Malignancies: Current Practice and Next Questions on Bispecific Antibodies

Share

Program Content

Activities

  • bsAbs in Hem Malignancies
    Redefining Precision Therapeutics in Hematologic Malignancies: Bispecific Antibodies
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 17, 2024

    Expires: May 17, 2025

  • 2024 APPlexus Bispecific Antibodies Heme
    Redefining Precision Therapeutics in Hematologic Malignancies: Current Practice and Next Questions on Bispecific Antibodies
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 05, 2024

    Expires: December 30, 2024

Faculty

cover img faculity

Sherry Adkins, MSN, ANP-C, FAAN

Advanced Practice Provider Supervisor
Department of Lymphoma/Myeloma
The University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO

Cleveland Clinic Taussig Cancer Institute
Department of Hematology and Medical Oncology
Member, Population and Cancer Prevention Program
Case Comprehensive Cancer Center
Cleveland, Ohio

Supporters

Supported by an education grant from Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC.

Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC